Antisense therapy
A new approach to killing C. difficile, the most common hospital-acquired bacterial infection in the US, is called antisense therapy.
Read moreA trusted source for Medicare news and education from the AMAC Foundation.
A new approach to killing C. difficile, the most common hospital-acquired bacterial infection in the US, is called antisense therapy.
Read more(By Lev Facher for ST A T) WASHINGTON — As legislation to address the opioid epidemic gains momentum, drug makers,
Read more(By Julie Appleby and Sydney Lupkin for Kaiser Health News) President Donald Trump wants to control spending on drugs. One
Read more(By Casey Ross for ST A T) Immunotherapy is a source of great hope in cancer care. It has rescued
Read moreIn a recent government report, Medicare recipients filled fewer prescriptions for pricey brand-name drugs but spent more on such meds
Read more(By Barak Richman and Kevin Schulman for ST A T) Pharmacy benefit managers, which long ran under the public radar,
Read more(By Erin Mershon for ST A T) WASHINGTON — Sen. Ron Johnson, the author of the federal “right-to-try” law signed
Read moreThe US Food and Drug Administration (FDA) said it has committed to taking new steps to address the root cause
Read more(By Mackenzie Bean for Becker’s Hospital Review ) Global antibiotic shortages, caused by a fragile drug supply chain, are contributing
Read moreThe Bipartisan Budget Act of 2018 accelerates the closure of the Medicare’s Part D “doughnut hole.” In 2019, those retirees
Read more